Responding to the coronavirus pandemic is very clearly a global challenge and for an international organization like BM TRADA, it reaches into all corners of our world. Our teams have been demonstrating a huge amount of resilience in the way in which they are responding to a situation that is constantly evolving and bringing uncertainty to the way in which we must now live and work.

We continue to review all advice from the World Health Organization (WHO), national and local governments and other relevant authorities to agree the necessary actions to protect our people, communities and our business in these challenging times. Where we can, we are remaining open – especially where we carry out work supporting critical industries. In all cases, we have implemented appropriate distancing and hygiene measures, ensuring our teams can work safely at all times, and where work can be performed from home, our employees are doing so. 

Customers are being regularly updated on our services to limit any potential disruption to their supply chain, and we are continuing to comply with any extra measures they request.
Our laboratories are starting to contribute directly to the fight against coronavirus, and in the UK we are providing our expertise, free of charge, to manufacturers and the government to test rapidly-manufactured ventilators to ensure that they are safe for use in hospitals. Read about it here.

A US-based colleague was called up for active duty with the US Air Force, to explore options to help fight the coronavirus in places like gymnasiums and community centers and is also part of a team assisting with the evacuation of two healthcare facilities due to the outbreak.

Colleagues in laboratories across the UK, Germany, and US-based laboratories have been manufacturing their own World Health Organization approved recipe hand sanitizer, using standard inventory chemicals from their facilities. 
BM TRADA remains committed to supporting all our stakeholders and we will continue to provide regular updates on the impact of coronavirus and our evolving response to the pandemic.